scholarly journals Cervical adenocarcinoma in situ : Human papillomavirus types and incidence trends in five states, 2008–2015

2019 ◽  
Vol 146 (3) ◽  
pp. 810-818 ◽  
Author(s):  
Angela A. Cleveland ◽  
Julia W. Gargano ◽  
Ina U. Park ◽  
Marie R. Griffin ◽  
Linda M. Niccolai ◽  
...  
2002 ◽  
Vol 86 (3) ◽  
pp. 361-364 ◽  
Author(s):  
Alexander W. Kennedy ◽  
Charles V. Biscotti

2017 ◽  
Vol 96 (4) ◽  
pp. 432-437 ◽  
Author(s):  
Aime Munro ◽  
Jim Codde ◽  
Katrina Spilsbury ◽  
Colin J.R. Stewart ◽  
Nerida Steel ◽  
...  

Author(s):  
Colin R. Laverty ◽  
Annabelle Farnsworth ◽  
Julia Thurloe ◽  
Ronald Bowditch

2007 ◽  
Vol 106 (1) ◽  
pp. 170-176 ◽  
Author(s):  
Silvano Costa ◽  
Giovanni Negri ◽  
Mario Sideri ◽  
Donatella Santini ◽  
Giuseppe Martinelli ◽  
...  

2017 ◽  
Vol 141 (12) ◽  
pp. 1653-1667 ◽  
Author(s):  
Edyta C. Pirog

Context.— Cervical adenocarcinomas span a diverse group of tumors with several distinct histologic tumor types, which include endocervical, endometrioid, intestinal, villoglandular, gastric, signet ring, serous, clear cell, and mesonephric. Diagnosis of cervical adenocarcinoma, especially early diagnosis, poses a significant challenge. Objective.— To review the pathogenesis, diagnostic criteria, immunohistochemical markers, and differential diagnosis of various subtypes of human papillomavirus (HPV)–positive and HPV-negative cervical adenocarcinomas. The paper presents a concise summary of the issues that may be particularly difficult in histopathologic diagnosis, such as differentiating neoplastic lesions from benign mimics, determining the tumor type, differentiating early invasive lesions from adenocarcinoma in situ, measuring the depth of invasion, and, finally, differentiating primary cervical adenocarcinoma from uterine endometrioid adenocarcinoma and tumors metastatic from other primary sites. Data Sources.— The study employed a PubMed search of recently published reports. Conclusions.— Early detection of HPV-positive tumor types may be aided with the expansion of HPV testing; however, early diagnosis of HPV-negative cervical adenocarcinomas will continue to pose a challenge and may require the development of additional molecular testing techniques.


Sign in / Sign up

Export Citation Format

Share Document